HilleVax Inc
NASDAQ:HLVX
HilleVax Inc Stock, NASDAQ:HLVX
321 Harrison Avenue, Suite 500, Boston, Massachusetts 02118
United States of America
Phone: +1.617.213.5054
Number of Employees: 90
Description
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.